Search results
Results from the WOW.Com Content Network
This is the list of Schedule III controlled substances in the United States as defined in section 202 of the Controlled Substances Act (21 U.S.C. § 812) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule:
The following findings are required, by section 202 of that Act, for substances to be placed in this schedule: The drug or other substance has a high potential for abuse. The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
1.3.2 3,6-diesters of morphine. ... This is a list of opioids, opioid antagonists and inverse agonists. ... List of Schedule I drugs (US) Gray death;
For example, in NSW the prescribing of Schedule 8 CNS stimulant medication (e.g., methylphenidate, dexamfetamine) requires authorisation from the NSW Ministry of Health (Pharmaceutical Services) and is generally restricted to specialists, such as paediatricians and psychiatrists.
The list is designated within the Controlled Substances Act [1] but can be modified by the U.S. Attorney General as illegal manufacturing practices change. Although the list is controlled by the Attorney General, the list is considered a DEA list because the DEA publishes and enforces the list.
Schedule 2 may refer to: Second Schedule of the Constitution of India, about the rights of government officials; Schedule II Controlled Substances within the US Controlled Substances Act List of Schedule II drugs (US) Schedule II Controlled Drugs and Substances within the Canadian Controlled Drugs and Substances Act
Clinics that dispensed painkillers proliferated with only the loosest of safeguards, until a recent coordinated federal-state crackdown crushed many of the so-called “pill mills.” As the opioid pain meds became scarce, a cheaper opioid began to take over the market — heroin. Frieden said three quarters of heroin users started with pills.
The structure-activity relationship of the drug class has been explored to a reasonable extent. The optimal substitution pattern is fairly tightly defined (i.e. N,N-diethyl on the amine nitrogen, 4-ethoxy on the benzyl ring and 5-nitro on the benzimidazole ring), but even derivatives incorporating only some of these features are still potent opioids.